Department Introduction

Rheumatology and Immunology | Our Speciality

:::

Our Speciality

Management of Refractory Autoinflammatory Diseases (Primarily Adult-Onset Still’s Disease/AOSD)

▪ Provides a comprehensive one-stop medical service for AOSD.
▪ SNQ National Quality Certification (2022-2024).
▪ 35 SCI-indexed publications—the highest number of single-center publications globally.
▪ Research findings have been widely cited over 1,500 times and have received four patents (two from the United States and two from Taiwan).

Innovative allogeneic adipose-derived stem cell therapy for Connective Tissue Diseases with Interstitial Lung Disease (ILD)

▪ Conducting a Phase I/IIa clinical trial, which has been approved by Taiwan’s Ministry of Health and Welfare.

Personalized Screening and Prevention for Rheumatic Disease Comorbidities

▪ A patient-centered case management system with Risk Management Plans (RMPs), ensuring zero adverse events in the past 10 years.
▪ 20 SCI-indexed publications.
▪ Two patents (one in the United States and one in Taiwan).
▪ Developing the first Asia-Pacific guidelines for RA comorbidity prevention and management, cited 37 times in the past three years.

Stay connected with CMUH
How to get to CMUH the map of hospital
百度 搜狗 360搜索 【人民需要这样的教育家】霍懋征:以爱育爱 以慧启慧 俄罗斯一城市大规模停电 中国关于反对美国滥施关税的立场 洛夫顿13铁致命失误满盘皆输 上海大杀器被锁死 江南华南等地多降雨 西北地区多大风天气

      <code id='17d4d'></code><style id='d6619'></style>
    • <acronym id='bd149'></acronym>
      <center id='358c2'><center id='5f07d'><tfoot id='98194'></tfoot></center><abbr id='810d7'><dir id='2c1c8'><tfoot id='0fece'></tfoot><noframes id='337a2'>

    • <optgroup id='98fda'><strike id='76370'><sup id='63f79'></sup></strike><code id='2181c'></code></optgroup>
        1. <b id='5a4d8'><label id='7c7a8'><select id='5b883'><dt id='b6484'><span id='bbe36'></span></dt></select></label></b><u id='82904'></u>
          <i id='b1015'><strike id='6dada'><tt id='a7432'><pre id='ba787'></pre></tt></strike></i>